Try our Advanced Search for more refined results
August 29, 2013
GlaxoSmithKline LLC v. Banner Pharmacaps, Inc.
Case Number:
13-1594
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 24, 2014
Fed. Circ. Upholds GSK Win Over Avodart Patent
The Federal Circuit on Monday upheld a Delaware district court's ruling that Banner Pharmacaps Inc., Mylan Pharmaceuticals Inc. and other generic-drug makers failed to prove that a patent owned by British pharmaceutical company GlaxoSmithKline LLC for the prostate reduction pill Avodart was invalid.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login